Duquesne Family Office LLC / ELVN
Duquesne Family Office LLC’s Enliven Therapeutics Inc Position
Does Duquesne Family Office LLC own Enliven Therapeutics Inc (ELVN)? Not currently — the last reported position was 947.4K shares worth $19M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$19M
Q3 2025
Shares
947.4K
% of Portfolio
+0.48%
Quarters Held
2
position exited
Position History ELVN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of ELVN.